Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,254 across all filing types
Latest filing 2012-02-23 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
北京市国枫律师事务所关于公司申请首次公开发行股票并在创业板上市的补充法律意见之六
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm (Beijing Grandfield Law Offices) regarding the application for initial public offering (IPO) and listing on the Growth Enterprise Market (创业板) of Changsha Sinocare Inc. It references multiple prior legal opinion letters and audit reports, and discusses compliance with relevant laws and regulations for the IPO process. The document is not a financial report itself but a legal opinion supporting the IPO application. It is a supplementary legal opinion (补充法律意见书) related to the IPO process. This type of document is best classified under Regulatory Filings (RNS) as it is a regulatory compliance/legal document that does not fit into other specific categories such as Annual Report, Audit Report, or Capital/Financing Update. The document length is 5718 characters, which is substantial but the content is legal opinion rather than financial data or report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2012-02-23 Chinese
北京市国枫律师事务所关于公司申请首次公开发行股票并在创业板上市的补充法律意见之八
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding a company's application for initial public offering (IPO) and listing on the Growth Enterprise Market (创业板). It references the company's audited financial statements for 2009, 2010, and 2011, and discusses compliance with relevant laws and regulations for IPO approval. The document is a supplementary legal opinion (补充法律意见书) related to the IPO process, not the IPO prospectus itself or a financial report. It is a legal advisory document supporting the IPO application, which fits best under Regulatory Filings (RNS) as it does not constitute an Annual Report, Audit Report, or other specific financial report type. The document length is over 10,000 characters and contains detailed legal and compliance information, not just an announcement or certification. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2012-02-23 Chinese
中信证券股份有限公司关于公司首次公开发行股票并在创业板上市之发行保荐书
Capital/Financing Update Classification · 95% confidence The document is titled "发行保荐书" which translates to "Sponsorship Letter for Issuance" and is issued by 中信证券股份有限公司 (CITIC Securities Co., Ltd.) regarding the initial public offering (IPO) of 长沙三诺生物传感技术股份有限公司 on the Growth Enterprise Market (创业板). The content includes detailed descriptions of the sponsor's responsibilities, due diligence, internal review procedures, legal and financial compliance, risk factors, and the company's business and financial conditions. It discusses the IPO process, regulatory compliance, and the sponsor's conclusion supporting the IPO. This document is a formal sponsorship or underwriting letter related to the IPO process, which is a capital market activity involving financing and issuance of new shares. It is not a financial report like an annual or interim report, nor is it a voting result or management change announcement. It is a detailed capital/financing update document related to the issuance of new shares and listing on the stock exchange. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains substantive content, not just an announcement or certification, so it is not RPA or RNS.
2012-02-23 Chinese
关于公司设立以来股本演变情况的说明及其董事、监事、高级管理人员的确认意见
Share Issue/Capital Change Classification · 95% confidence The document is a detailed explanation of the company's share capital evolution since its establishment, including historical changes in shareholding, capital increases, share transfers, and confirmations by directors, supervisors, and senior management. It references audit and capital verification reports, but the primary content is about the company's capital structure changes and related confirmations. There is no indication that this is a full annual report, earnings release, or other financial statement. The document is not a brief announcement but a substantive report on share capital evolution and confirmations by company officers. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2012-02-23 Chinese
北京市国枫律师事务所关于公司申请首次公开发行股票并在创业板上市的法律意见
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion issued by a law firm regarding the application for an initial public offering (IPO) and listing on the Growth Enterprise Market (创业板) by Changsha Sannuo Biosensor Technology Co., Ltd. It includes extensive legal review of the company's qualifications, governance, shareholding, business operations, compliance with laws and regulations, and other IPO-related matters. The document references various legal and regulatory frameworks, audit reports, internal control reports, and other supporting documents related to the IPO process. It is not a financial report, earnings release, or a simple announcement but a comprehensive legal opinion supporting the IPO application. This type of document is best classified under Regulatory Filings (RNS) as it is a regulatory compliance document related to the IPO process and does not fit into other more specific categories such as Annual Report, Audit Report, or Capital/Financing Update. The document length (15,000 characters) and content confirm it is a full legal opinion rather than a brief announcement or certification.
2012-02-23 Chinese
公司章程（上市修订草案）
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association (章程) for Changsha Sinocare Co., Ltd. It includes comprehensive sections on company organization, shareholder rights, board of directors, shareholder meetings, share issuance and transfer, and other governance matters. It references Chinese company law and securities law, and covers procedural rules for shareholder meetings, board responsibilities, and internal governance. There is no indication of financial statements, audit reports, earnings data, or announcements of voting results. The content is focused on governance structure and rules, which aligns with Governance Information filings. The document length is substantial (15,000 characters), indicating it is the full governance document, not a brief announcement or summary. Therefore, the appropriate classification is Governance Information (CGR).
2012-02-23 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.